Arcadia Biosciences Stock In The News

RKDA Stock  USD 3.85  0.24  5.87%   
Our overall analysis of Arcadia Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Arcadia Biosciences. The specific impact of Arcadia Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Arcadia Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Arcadia Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Arcadia Biosciences Backtesting and Arcadia Biosciences Hype Analysis.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Arcadia Biosciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
https://www.globenewswire.com/news-release/2025/08/14/3133924/35730/en/Arcadia-Biosciences-RKDA-Announces-Second-Quarter-and-First-Half-2025-Financial-Results-and-Business-Highlights.html
 Bullish
Macroaxis News: globenewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BASE, RKDA on Behalf of Shareholders
https://www.globenewswire.com/news-release/2025/08/04/3126790/0/en/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-SPTN-BASE-RKDA-on-Behalf-of-Shareholders.html
 Bullish
Macroaxis News: globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Noti...
https://www.globenewswire.com/news-release/2025/08/04/3126759/0/en/BRODSKY-SMITH-SHAREHOLDER-UPDATE-Notifying-Investors-of-the-Following-Investigations-HilleVax-Inc-Nasdaq-HLVX-Steelcase-Inc-NYSE-SCS-LAVA-Therapeutics-N-V-Nasdaq-LVTX-Arcadia-Biosc.html
 Bullish
Macroaxis News: globenewswire.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
https://www.globenewswire.com/news-release/2025/05/08/3077227/35730/en/Arcadia-Biosciences-RKDA-Announces-First-Quarter-2025-Financial-Results-and-Business-Highlights.html
 Bullish
Macroaxis News: globenewswire.com
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
https://www.globenewswire.com/news-release/2025/04/29/3070175/35730/en/Arcadia-Biosciences-RKDA-Announces-Date-of-First-Quarter-2025-Financial-Results-and-Business-Highlights-Conference-Call.html
 Bullish
Macroaxis News: globenewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDW, EBTC, RKDA on Behalf of Shareholders
https://www.globenewswire.com/news-release/2025/02/17/3027362/0/en/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-RDW-EBTC-RKDA-on-Behalf-of-Shareholders.html
 Neutral
Macroaxis News: globenewswire.com
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC
https://www.globenewswire.com/news-release/2025/02/14/3026930/0/en/TOCKHOLDER-ALERT-The-M-A-Class-Action-Firm-Continues-To-Investigate-The-Merger-EVGR-QTRX-RKDA-EBTC.html
 Bullish
Yahoo News
11 Best Farmland and Agriculture Stocks To Buy According to Analysts
https://finance.yahoo.com/news/11-best-farmland-agriculture-stocks-234022312.html
 Bullish
Yahoo News
13 Most Advanced Countries in Agriculture Technology
https://finance.yahoo.com/news/13-most-advanced-countries-agriculture-172109432.html
 Bullish
Yahoo News
Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia Biosciences
https://finance.yahoo.com/news/zacks-industry-outlook-highlights-bunge-105410440.html
 Bullish

Arcadia Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Arcadia and other traded companies coverage with news coverage. We help investors stay connected with Arcadia headlines for the 25th of August to make an informed investment decision based on correlating the impacts of news items on Arcadia Stock performance. Please note that trading solely based on the Arcadia Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Arcadia Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Arcadia Biosciences investors visualize upcoming and past events in order to time the market based on Arcadia Biosciences noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arcadia Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arcadia Biosciences' short interest history, or implied volatility extrapolated from Arcadia Biosciences options trading.
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out Arcadia Biosciences Backtesting and Arcadia Biosciences Hype Analysis.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.285
Earnings Share
(5.19)
Revenue Per Share
3.96
Quarterly Revenue Growth
0.114
Return On Assets
(0.33)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.